Litigation Details for Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. (D. Del. 2014)
✉ Email this page to a colleague
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. (D. Del. 2014)
Docket | ⤷ Sign Up | Date Filed | 2014-06-25 |
Court | District Court, D. Delaware | Date Terminated | 2015-10-30 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Parties | NOVARTIS PHARMA AG | ||
Patents | 6,465,504; 6,596,750 | ||
Attorneys | Bindu Ann George Palapura | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc.
Details for Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. (D. Del. 2014)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2014-06-25 | 1 | an action for patent infringement of U.S. Patent Nos. 6,465,504 (“the ’504 Patent”) and 6,596,750…The ’504 Patent and the ’750 Patent are collectively referred to herein as the “Patents-in-Suit.”…the ’504 Patent and the ’750 Patent; 2. A judgment that the ’504 Patent and the …6,596,750 (“the ’750 Patent”), arising under the patent laws of the United States, Title 35, United States…with respect to EXJADE®: the ’504 Patent and the ’750 Patent. | External link to document | |
2015-10-30 | 106 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,465,504; 6,596,750. (Attachments…2014 30 October 2015 1:14-cv-00820 830 Patent None District Court, D. Delaware | External link to document | |
2014-06-25 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,465,504; 6,596,750;. (cla, …2014 30 October 2015 1:14-cv-00820 830 Patent None District Court, D. Delaware | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |